FDA OKs First Cellular Therapy for Melanoma
Lifileucel approved as treatment for advanced melanoma after anti-PD-1 and targeted therapy
Stay updated with breaking news from Peter Marks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lifileucel approved as treatment for advanced melanoma after anti-PD-1 and targeted therapy
The FDA approved the first-ever T cell therapy for advanced melanoma.
The FDA approved Amtagvi, the first cellular therapy for the treatment of adults with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor.
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a...
Rubenstein to Conclude Kennedy Center Chairmanship